comparemela.com

Latest Breaking News On - French national academy of pharmacy - Page 2 : comparemela.com

GenSight Biologics Strengthens Its Management Team to Support the Launch of LUMEVOQ® in Europe

Philippe Motté as Senior VP, Regulatory and QualityMichiel Hemels as VP, Global Pricing and Market AccessPARIS (BUSINESS WIRE) Regulatory News:GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for reti.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.